These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 30640888

  • 1. Catecholaminergic Polymorphic Ventricular Tachycardia: The Cardiac Arrest Where Epinephrine Is Contraindicated.
    Bellamy D, Nuthall G, Dalziel S, Skinner JR.
    Pediatr Crit Care Med; 2019 Mar; 20(3):262-268. PubMed ID: 30640888
    [Abstract] [Full Text] [Related]

  • 2. Description of a novel RyR2 mutation in a juvenile patient with symptomatic catecholaminergic polymorphic ventricular tachycardia in sleep and during exercise: a case report.
    Seidlmayer LK, Riediger F, Pagonas N, Nordbeck P, Ritter O, Sasko B.
    J Med Case Rep; 2018 Oct 09; 12(1):298. PubMed ID: 30296944
    [Abstract] [Full Text] [Related]

  • 3. Catecholaminergic polymorphic ventricular tachycardia found in an adolescent after a methylenedioxymethamphetamine and marijuana-induced cardiac arrest.
    Diffley M, Armenian P, Gerona R, Reinhartz O, Avasarala K.
    Crit Care Med; 2012 Jul 09; 40(7):2223-6. PubMed ID: 22584762
    [Abstract] [Full Text] [Related]

  • 4. A novel variant in RyR2 causes familiar catecholaminergic polymorphic ventricular tachycardia.
    Bosch C, Campuzano O, Sarquella-Brugada G, Cesar S, Perez-Serra A, Coll M, Mademont I, Mates J, Del Olmo B, Iglesias A, Brugada J, Petersen V, Brugada R.
    Forensic Sci Int; 2017 Jan 09; 270():173-177. PubMed ID: 27988446
    [Abstract] [Full Text] [Related]

  • 5. Advances in the diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia.
    Roston TM, Cunningham TC, Sanatani S.
    Cardiol Young; 2017 Jan 09; 27(S1):S49-S56. PubMed ID: 28084961
    [Abstract] [Full Text] [Related]

  • 6. Arrhythmogenic mechanisms in a mouse model of catecholaminergic polymorphic ventricular tachycardia.
    Cerrone M, Noujaim SF, Tolkacheva EG, Talkachou A, O'Connell R, Berenfeld O, Anumonwo J, Pandit SV, Vikstrom K, Napolitano C, Priori SG, Jalife J.
    Circ Res; 2007 Nov 09; 101(10):1039-48. PubMed ID: 17872467
    [Abstract] [Full Text] [Related]

  • 7. A delayed diagnosis of catecholaminergic polymorphic ventricular tachycardia with a mutant of RYR2 at c.7580T>G for 6 years in a 9-year-old child.
    Duan H, Lu Y, Yan S, Qiao L, Hua Y, Li Y, Zhou K, Wang C.
    Medicine (Baltimore); 2018 Apr 09; 97(16):e0368. PubMed ID: 29668588
    [Abstract] [Full Text] [Related]

  • 8. Survival in a young child with out-of-hospital cardiac arrest: diagnostic dilemma and when to deviate from standard resuscitation guidelines.
    Collins NJ, Finn D, O'Mahony O, Walsh M.
    BMJ Case Rep; 2023 Oct 18; 16(10):. PubMed ID: 37852665
    [Abstract] [Full Text] [Related]

  • 9. Clinical and genetic profile of catecholaminergic polymorphic ventricular tachycardia in Hong Kong Chinese children.
    Yu TC, Liu AP, Lun KS, Chung BH, Yung TC.
    Hong Kong Med J; 2016 Aug 18; 22(4):314-9. PubMed ID: 27256466
    [Abstract] [Full Text] [Related]

  • 10. A rare cause of sudden cardiac arrest: Catecholaminergic polymorphic ventricular tachycardia.
    Atik SU, Alp FE, Dedeoğlu R, Koka A, Öztunç F, Eroğlu AG.
    Turk Pediatri Ars; 2018 Jun 18; 53(2):124-128. PubMed ID: 30116135
    [Abstract] [Full Text] [Related]

  • 11. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia.
    Priori SG, Napolitano C, Tiso N, Memmi M, Vignati G, Bloise R, Sorrentino V, Danieli GA.
    Circulation; 2001 Jan 16; 103(2):196-200. PubMed ID: 11208676
    [Abstract] [Full Text] [Related]

  • 12. Insights on the mechanism of flecainide in catecholaminergic polymorphic ventricular tachycardia.
    Davidson R, Medeiros M.
    J Med Life; 2023 Aug 16; 16(8):1294-1296. PubMed ID: 38024821
    [Abstract] [Full Text] [Related]

  • 13. Catecholaminergic Polymorphic Ventricular Tachycardia as the Etiology of Emergency Medical Services-Reported Traumatic Arrest.
    Bailey J, Berkeley RP.
    Pediatr Emerg Care; 2018 Nov 16; 34(11):e219-e222. PubMed ID: 27668923
    [Abstract] [Full Text] [Related]

  • 14. Flecainide Reduces Ventricular Arrhythmias in Patients With Genotype RyR2-positive Catecholaminergic Polymorphic Ventricular Tachycardia.
    Wangüemert Pérez F, Hernández Afonso JS, Groba Marco MDV, Caballero Dorta E, Álvarez Acosta L, Campuzano Larrea O, Pérez G, Brugada Terradellas J, Brugada Terradellas R.
    Rev Esp Cardiol (Engl Ed); 2018 Mar 16; 71(3):185-191. PubMed ID: 28789916
    [Abstract] [Full Text] [Related]

  • 15. Identification of a novel exon3 deletion of RYR2 in a family with catecholaminergic polymorphic ventricular tachycardia.
    Dharmawan T, Nakajima T, Ohno S, Iizuka T, Tamura S, Kaneko Y, Horie M, Kurabayashi M.
    Ann Noninvasive Electrocardiol; 2019 May 16; 24(3):e12623. PubMed ID: 30615235
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A de novo novel cardiac ryanodine mutation (Ser4155Tyr) associated with catecholaminergic polymorphic ventricular tachycardia.
    Mantziari L, Vassilikos V, Anastasakis A, Kotsaka X, Paraskevaidis S, Styliadis IH, Luria D.
    Ann Noninvasive Electrocardiol; 2013 Nov 16; 18(6):571-6. PubMed ID: 24147812
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pediatric Catecholaminergic Polymorphic Ventricular Tachycardia: A Translational Perspective for the Clinician-Scientist.
    Kallas D, Lamba A, Roston TM, Arslanova A, Franciosi S, Tibbits GF, Sanatani S.
    Int J Mol Sci; 2021 Aug 27; 22(17):. PubMed ID: 34502196
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.